New partnerships and study collaborations, the events where you'll find us, and our thinking on tumour-informed ctDNA and where it's taking cancer care.
Simsen Diagnostics Partners with One-carbon Therapeutics for Groundbreaking ODIN Cancer Trial Simsen Diagnostics, a leader in ultra-sensitive analysis…
Developing effective cancer treatments is one of the most challenging frontiers in drug development, where precision, timing, and sensitivity can dram…
Simsen Diagnostics is excited to announce our participation in the upcoming GoCo Investor Day, a leading gathering for innovation, investment, and col…
We are proud to announce a new partnership with a Swedish hospital, paving the way for transformative advancements in personalised cancer care. This c…
We are pleased to announce that our CEO, Pontus Rehn, will represent Simsen Diagnostics at the upcoming Ecosystem Exchange: Life Sciences 2025, hosted…
Tell us about your study and your endpoints. A real scientist in CET/CEST will reply.
